The drug, Abirateronone Acetate in combination with Pregnisone, look like it will work well together, but I have one doubt and though, I would highly recommend, the drug Pregnisone, There is a problem with the other drug Abiraterone is just an other anti- sex hormone therapy drug that blocks the production of sex hormones like testosterone to the whole of the prostrate cancer patient body. I’ve read that that Abiraterone may not work if the prostrate cancer patient has been on any anti- sex hormone therapy drug, and the anti- sex hormone therapy drug has stopped working , I still think what we need is a drug that just works on the prostate cancer and dos not deplete the whole of the patient body of testosterone
This next two bits are from Wikipedia
http://en.wikipedia.org/wiki/Prednisone
Prednisone is a synthetic corticosteroid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. It is used to treat certain inflammatory diseases and (at higher doses) cancers, but has significant adverse effects. It is usually taken orally but can be delivered by intramuscular injection or intravenous injection. It has a mainly glucocorticoid effect. Prednisone is a prodrug that is converted by the liver into prednisolone, which is the active drug and also a steroid.
also from Wikipedia Abiraterone is a drug currently under investigation for use in prostate cancer. It blocks the formation of testosterone by inhibiting CYP17A1 (CYP450c17), an enzyme also known as 17α-hydroxylase/17,20 lyase.[1] This enzyme is involved in the formation of DHEA and androstenedione, which may ultimately be metabolized into testosterone. This drug was initially discovered and developed at the Institute of Cancer Research in London. Cougar Biotechnology is the biotechnology company conducting the research.[2] It has been announced that Cougar will be acquired by Johnson & Johnson in 2009. Subsequent to merger, J&J will conduct trials.[3]